Effect of adenosine A2A receptor agonist (CGS) on ischemia/reperfusion injury in isolated rat liver

Apoptosis

Volumn 10, Issue 5, 2005, Pages 955-962

  Ben Ari, Z ^a   Pappo, O ^a   Sulkes, J ^a   Cheporko, Y ^b   Vidne, B A ^b   Hochhauser, E ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Apoptosis; CGS; Injury; Ischemia reperfusion; Liver; Rat

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENOSINE A2A RECEPTOR AGONIST; CASPASE 3; LIVER ENZYME;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOCHEMISTRY; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FLUOROMETRY; IMMUNOHISTOCHEMISTRY; ISOLATED LIVER; LIVER INJURY; LIVER ISCHEMIA; MALE; NICK END LABELING; NONHUMAN; PERFUSION; PORTAL VEIN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE; UREA CYCLE;

ADENOSINE; ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; IN SITU NICK-END LABELING; LIVER; MALE; PHENETHYLAMINES; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A2A; REPERFUSION INJURY;

ANIMALIA;

EID: 24644452517     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-005-0440-3     Document Type: Article

References (36)

1. Furukawa H, Todo S, Imventarza O, et al. Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution. Transplantation 1991; 51: 1000-1004.
2. Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 1993; 55: 807-813.
3. Gao W, Bentley RC, Madden JF, Clavien PA. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology 1998; 27: 1652-1660.
4. Ikeda T, Yanaga K, Kishikawa K, Kakizoe S, Shimada M, Sugimachi K. Ischemic injury in liver transplantation: Differences in injury sites between warm and cold ischemia in rats. Hepatology 1992; 16: 454-461.
5. Natori S, Selzner M, Valentino KL, et al. Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism. Transplantation 1999; 68: 89-96.
6. Sindram D, Kohli V, Madden JF, Clavien PA. Calpain inhibition prevents sinusoidal endothelial cell apoptosis in the cold ischemia rat liver. Transplantation 1999; 68: 136-140.
7. Huet PM, Nagaoka MR, Desbiens G, et al. Sinusoidal endothelial cell and hepatocyte death following cold ischemia - warm reperfusion of the rat liver. Hepatology 2004; 39: 1110-1119.
8. Peralta C, Hotter G, Closa D, et al. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors. Hepatology 1999; 29: 126-132.
9. Peralta C, Hotter G, Closa D, et al. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: Role of nitric oxide and adenosine. Hepatology 1997; 25: 934-937.
10. Jenkins DP, Baxter GF, Yellon DM. The pathophysiology of ischemic preconditioning. Pharmacol Res 1995; 31: 219-224.
11. Wang J, Drake L, Sajjadi F, et al. Dual activation of adenosine A1 and A3 receptors mediates preconditioning of isolated cardiac myocytes. Eur J Pharmacol 1997; 320: 241-248.
12. Bruns RF, Lu GH, Pugsley TA. Characterization of the A2 adenosine receptor labeled by (3H)NECA in rat striatal membranes. Mol Pharmacol 1986; 29: 331-346.
13. Meldrum DR, MItchell MB, Banerjee A, Harken AH. Cardiac preconditioning. Inductin of endogenous tolerance to ischemia-reperfusion injury. Arch Surg 1993; 128: 1208-1211.
14. Stella L, Berrino L, Filippelli A, de Novellis V, et al. Nitric oxide participates in the hypotensive effect induced by adenosine A2 subtype receptor stimulation. J Cardiovasc Pharmacol 1995; 25: 1001-1005.
15. Lasley RD, Jahania MS, Mentzner JM Jr. Beneficial effects of adenosine A(2a) agonist CGS-21680 in infarcted and stunned porcine myocardium. Am J Physiol Heart Circ Physiol 2001; 280: H1660-H1666.
16. Arai M, Thurman RG, Lemasters JJ. Contribution of adenosine A(2) receptor and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against Storage/Reperfusion injury in rat livers. Hepatology 2000; 32: 297-302.
17. Harada N, Okajima K, Murakami K, et al. Adenosine and selective A2 receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation. J Pharmacol Exp Ther 2000; 294: 1034-1042.
18. Nakayama H, Yamamoto Y, Kume M, et al. Pharmacologic stimulation of adenosine A2 receptor supplants ischemic preconditioning in providing ischemic tolerance in rat livers. Surgery 1999; 126: 945-954.
19. Weinbroum A, Nielsen VG, Tan S, et al. Liver ischemia-reperfusion increases pulmonary permeability in rat: Role of circulating xanthine oxidase. Am J Physiol 1995; 266: G988-G996.
20. Minor T, Akbar S, Yamamoto Y. Adenosine A2 receptor stimulation protects the predamaged liver from cold preservation through activation of cyclic adenosine monophosphate-protein kinase A pathway. Liver Transplant 2000; 6: 196-200.
21. Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003; 125: 1246-1257.
22. Rudiger HA, Graf R, Clavien PA. Liver ischemia: Apoptosis as a central mechanism of injury. J Invest Surg 2003; 16: 149-159.
23. Sindram D, Rudiger H, Upadhya A, et al. Ischemic preconditioning protects against cold ischemic injury through an oxidative stress-dependent mechanism. J Hepatol 2002; 36: 78-84.
24. Carini R, De Cesaris M, Splendore R, et al. Signal pathway involved in the development of hypoxic preconditioning in rat hepatocytes. Hepatology 2001; 33: 131-139.
25. Carini R, De Cesaris M, Splendore R, et al. Ischemic preconditioning reduced Na+ accumulation and cell killing in isolated rat hepatocytes exposed to hypoxia. Hepatology 2000; 31: 166-172.
26. Pajdo R, Brzozowski T, Konturek PC, et al. Ischemic preconditioning, the most effective gastroprotective intervention: Involvement of prostaglandins, nitric oxide, adenosine and sensory nerves. Eur J Pharmacol 2001; 427: 263-276.
27. Serracino-Inglott F, Virlos IT, Habib NA, Williamson RCN, Mathie RT. Adenosine preconditioning attenuates hepatic reperfusion injury in the rat by preventing the down-regulation of endothelial nitric oxide synthase. BMC Gastroenterology 2002; 2: 22.
28. Reinstein LJ, Lichtman SN, Currin RT, Wang J, Thurman RG, Lemasters JJ. Suppression of lipopolysaccharide-stimulated release of tumor necrosis factor by adenosine: Evidence for A2 receptors on rat Kupffer cells. Hepatology 1994; 19: 1445-1452.
29. Carini R, De Cesaris MG, Splendore R, et al. Signal pathway involved in the development of hypoxic preconditioning in rat hepatocytes. Hepatology 2001; 33: 131-139.
30. Carini R, Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology 2003; 125: 1480-1491.
31. Carini R, De Cesaris MG, Splendore R, et al. Signal pathway responsible for hepatocyte preconditioning by nitric oxide. Free Rad Biol Med 2003; 34: 1047-1055.
32. Carini R, De Cesaris MG, Splendore R, et al. Role of phosphatidylinositol 3-kinase in the development of hepatocyte preconditioning. Gastroenterology 2004; 127: 914-923.
33. Ness KV, Podkameni D, Schwartz M, Boros P, Miller C. Dibutyryl cAMP reduces nonparenchymal cell damage during cold preservation pf rat livers. J Surg Res 1995; 58: 728-731.
34. Hochhauser E, Kaminski O, Shalom H, et al. Role of adenosine receptor activation in antioxidant enzyme regulation during ischemia-reperfusion in the isolated rat heart. Antioxid Redox Signal 2004; 6: 335-344.
35. Leesar MA, Stoddard M, Ahmed M, Broadbent J, Bolli R. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation 1997; 95: 2500-2507.
36. Yadav SS, Sindram D, Perry DK, Clavien PA. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology 1999; 30: 1223-1231.